Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.
Reads0
Chats0
TLDR
Findings suggest that binding of drug-induced antibodies to platelets occurs at the Fab domains of the IgG molecule.Abstract:
Platelets coated with quinine- or quinidine-induced antibodies form rosettes around protein A-Sepharose beads and normal platelets form rosettes about protein A-Sepharose beads coated with these antibodies. These reactions occurred only in the presence of sensitizing drug. Platelets also formed rosettes about protein A-Sepharose beads coated with an anti-PIA1 antibody, but drug was not required. Formation of rosettes between antibody-coated platelets and protein A-Sepharose was inhibited by F(ab')2 fragments of goat antibody specific for the Fc portion of human IgG, while rosette formation between antibody-coated protein A-Sepharose and platelets was inhibited by F(ab')2 fragments directed against the F(ab')2 portion of the IgG molecule. Since binding of IgG to protein A is known to occur via the Fc region, these findings suggest that binding of drug-induced antibodies to platelets occurs at the Fab domains of the IgG molecule.read more
Citations
More filters
Guillain-Barre Sendromlu Hastada İntravenöz İmmünglobulin Tedavisi Sonrası Gelişen Trombositopeni
Ali Kutlucan,Murat Erdoğan,Süber Dikici,Yusuf Aydin,Hulya Coskun,Gökhan Celbek,Görkem Sucu,Nurten Ercan +7 more
TL;DR: A 36-year-old female patient, who diagnosed as GuillainBarre and had an idiopathic thrombocytopenic purpura attack 18 month ago, is treated 5 day course of 30 g/day dose of IVIG and platelet counts became to normal ranges after cyclosporine treatment.
Macrocytic anemia and thrombocytopenia induced by orlistat (case report)
Palacios Martinez David,Garcia Alvarez Juan Carlos,Montero Santamaria Nieves,Villar Ruiz Olga Patricia,Ruiz Garcia Antonio,Diaz Alonso Raquel Asuncion +5 more
Adverse drug reaction Quinine-mediated disseminated intravascular coagulation
R K Kedia,A J Wright +1 more
TL;DR: It is recommended that any patient on quinine who presents with DIC should be checked for quInine-dependent platelet antibodies and quinines should be discontinued forthwith.
Journal ArticleDOI
Naproxen-induced Immune Thrombocytopenia -A case report-
TL;DR: It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for NSAIDs on the basis of prior history and once they provide informed consent for surgery.
References
More filters
Journal ArticleDOI
A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies
Richard H. Aster,Sara E. Enright +1 more
TL;DR: It is concluded that, in PNH, platelets and granulocytes share the membrane defect characteristic of erythrocytes in this disorder, and these observations support the concept that PNH arises as the result of a somatic mutation in a primitive cell capable of differentiating into ery Throttleblast, myeloblast, and megakaryoblast lines.
Journal ArticleDOI
Allergic purpura, including purpura due to foods, drugs and infections.
TL;DR: Purpura occurring during convalescence can best be explained on the assumption of an allergic basis, similar perhaps to that to which nephritis following streptococcal infections has been attributed.
Journal ArticleDOI
Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.
TL;DR: Results of this study were consistent with the possibilities that the protein moiety of a haptenic antigen involved in development of an antibody which attaches to a cell is not necessarily a component of the cell, and that the cell reacts with the antibody by virtue of having a surface favorable for non-specific adsorption of certain haptene-antibody complexes.
Journal ArticleDOI
Cyclic AMP metabolism in cholesterol-rich platelets.
TL;DR: It is demonstrated that incorporation of cholesterol into platelet membranes is associated with a diminished inhibitory effect of prostaglandin E, on platelet aggregation and therefore adenosine 3’:5’-monophosphate production in these platelets.
Journal ArticleDOI
Drug-Antibody-Platelet Interaction in Quinine- and Quinidine-induced Thrombocytopenia
TL;DR: It is demonstrated that in quinine- and quinidine-induced thrombocytopenia, drug and antibody combine first in the soluble phase to form a complex, which then binds with high affinity to a receptor on the platelet surface (innocent bystander reaction), and that these antibodies are heterogeneous in respect to the amount of drug required to promote their binding to platelets, the number of platelet receptors they recognize, and their binding affinities.